LNG exporter Venture Global slashes IPO price range

Venture Global trades below IPO price in disappointing debut despite Trump's support of LNG industry
"The Trump administration has made very clear they support growing LNG exports," Venture CEO Mike Sabel told CNBC in an interview Friday.
LNG exporter Venture Global dips below IPO price in its trading debut
The energy company raised $1.75 billion by pricing 70 million shares at $25, the middle of its reduced $23 to $27 price range.
LNG exporter Venture Global raises $1.75 bln in US IPO
Liquefied natural gas exporter Venture Global said on Thursday it had raised $1.75 billion, marking the first big initial public offering of President Donald Trump's second term as investors bet on his plan to boost U.
LNG Exporter Venture Global Stock Trades Below IPO Price in Debut
Shares of liquefied natural gas exporter Venture Global debuted Friday below their initial public offering price of $25 per share.
Venture Global LNG Raises $1.75 Billion in IPO Amid Adjusted Valuation
Venture Global LNG has successfully raised $1.75 billion through its U.S. IPO after pricing 70 million shares at $25 each. The offering was adjusted from an initial plan of 50 million shares priced at $40 to $46 to
LNG pure-play Venture Global's IPO tests appetite for energy stocks under Trump administration
The Trump administration has made very clear they support growing LNG exports,” Venture CEO Mike Sable told CNBC in an interview Friday.
IPO market comeback: How recent major US listings fared
The U.S. IPO market is expected to see a blowout 2025, fueled by the return of business-friendly Donald Trump to the White ...
Venture Global’s Stumble Reflects Chilly State of the IPO Market
Venture Global launched its initial public offering with a lofty goal: Raise up to $2.3 billion at a $110 billion valuation ...
Ascentage Pharma CEO Dr. Yang on IPO
Dr. Dajun Yang, Ascentage Pharma CEO, joins 'Closing Bell Overtime' to talk today's IPO. Marilyn Manson won’t face sexual ...
Ascentage Pharma’s US Shares Climb After $126 Million IPO
Shares of Ascentage Pharma Group International rose as much as 4% in the Chinese biopharmaceutical company’s US trading debut ...
2024 Year In Review: IPO Market Overview
In 2024, global and US markets saw a slight increase in IPOs. Syntax Data used its FIS classification system to analyze the ...
3FPX, ARM : IPO Rebound In 2025? Here's What's Fueling The Boom,...
The year 2025 is expected to see a resurgence of IPOs due to policy changes, monetary easing, and a favorable business ...
Trump Partner Builds $1 Billion Stake From India Real Estate IPO
When Donald Trump’s real estate business wanted to break into the Indian market in 2012, it turned to Atul Chordia and his ...
Sionna Therapeutics Seeks $100 Million in IPO For Cystic Fibrosis Treatments
Sionna Therapeutics aims to raise $100 million in an IPO for cystic fibrosis drugs, backed by venture capital, targeting a ...